GSK wins latest Zantac trial as jury finds drug did not cause woman’s cancer pharma GSK - formerly GlaxoSmithKline - has won its latest trial over whether its most popular drug caused cancer on Monday, after a jury found it was not the root cause of an American woman's illness.
GSK: Good news for pharma giant as approval granted to expand vaccine use BUSINESS The FDA has expanded its approval of a GSK vaccine that prevents respiratory syncytial virus (RSV) to affect younger adults, in a move the company hopes will prevent thousands of hospitalisations each year.
Investors in London-listed medical tech firm continue battle to oust top brass BUSINESS Investors in a London-listed medical technology firm are continuing their campaign to oust the company’s top brass as its share price languishes.
US regulator accepts GSK’s application to expand treatment of cancer drug April 24, 2024 The treatment, Jemperli, will now be classed as being able to help all adult patients with primary advanced or recurrent endometrial cancer. It is used alongside chemotherapy.